We demonstrated NAFLD-HCC intrinsic METTL3 impaired CD8+ T cell antitumor response, with significant reductions in active CD8+ T cell subsets (IFN-γ+ and GZMB+) in liver-specific METTL3 knockin mice. This evidence concerns the gene CD8A and hepatocellular carcinoma.